ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IMPV Imperva, Inc.

55.74
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Imperva, Inc. NASDAQ:IMPV NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 55.74 45.00 199,999.99 0 00:00:00

WeissLaw LLP Investigates Imperva Inc. Acquisition

12/10/2018 3:52pm

PR Newswire (US)


Imperva, Inc. (NASDAQ:IMPV)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Imperva, Inc. Charts.

NEW YORK, Oct. 12, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Imperva Inc. ("IMPV" or the "Company") (NASDAQ: IMPV) in connection with the proposed acquisition of the Company by Thoma Bravo.  Under the terms of the acquisition agreement, shareholders will receive $55.75 in cash for each IMPV share they own.

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own IMPV shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Visit our website
http://www.weisslawllp.com/essendant-inc/

Or follow us on Twitter @MarketsAlert

WeissLaw is investigating whether IMPV's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, at least one analyst set a target price of $65.00 per IMPV share. 

Given these facts, WeissLaw is concentrating its investigation on whether IMPV's Board conducted a fair process in agreeing to the proposed acquisition, and whether the proposed acquisition undervalues the Company.    

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-investigates-imperva-inc-acquisition-300730200.html

SOURCE WeissLaw LLP

Copyright 2018 PR Newswire

1 Year Imperva, Inc. Chart

1 Year Imperva, Inc. Chart

1 Month Imperva, Inc. Chart

1 Month Imperva, Inc. Chart

Your Recent History

Delayed Upgrade Clock